Erectile dysfunction decisions — 2025

The Board denied the veteran's claims for increased ratings and earlier effective dates, as well as remanded several service connection claims.

The Board granted service connection for tinnitus, sleep apnea, cervical spine (neck) disability, lumbar spine (back) disability, right lower extremity radiculopathy, left lower extremity radiculopathy, and erectile dysfunction. The appeal was dismissed for major depressive disorder and generalized anxiety disorder due to the grant of an unspecified depressive disorder with anxious distress.

The Veteran's effective date for the award of service connection for erectile dysfunction and special monthly compensation (SMC) based on loss of use of a creative organ was granted as October 31, 2008, but no earlier.

The Board granted service connection for diabetes mellitus type II, hypertension, and atherosclerotic heart disease based on presumed exposure to herbicides. Erectile dysfunction was also granted as secondary to the service-connected hypertension. Hand tremors were denied.

The Board granted service connection for gastrointestinal, upper respiratory, and cardiovascular signs or symptoms effective August 10, 2022, but denied service connection for bilateral hearing loss and erectile dysfunction. Tinnitus was also granted.

The Board denied service connection for irritable bowel syndrome, gastroesophageal reflux disease, erectile dysfunction, and headaches as there is no evidence of a current disability.

The Board dismissed the veteran's appeal for service connection for multiple conditions due to an untimely Notice of Disagreement.

The Board granted service connection for erectile dysfunction, right knee strain, left knee strain, pseudofolliculitis barbae, somatic symptom disorder with predominant pain and generalized anxiety disorder, and throbbing head pain on a direct basis.

The Board remands the matter for additional development to ensure that the Veteran undergoes a VA examination or VA record review and advisory medical opinion for his eyes.

The Board remands the claims for service connection for prostate cancer, erectile dysfunction, and residuals of left rib cage contusion to obtain a new VA medical opinion.

The Board remands the claim for an adequate medical opinion regarding the etiology of erectile dysfunction, considering its relationship to service-connected conditions and other factors.

The Board denied service connection for urinary frequency and erectile dysfunction as the evidence did not support a current diagnosis of these conditions during the pendency of the claim.

The Board granted service connection for PTSD and right hand scar, but denied service connection for other claimed conditions including diabetes type II, erectile dysfunction, headaches, heart disease, obstructive sleep apnea, left shoulder injury, left hand injury, lower back injury, right shoulder injury, upper back injury, and a compensable rating for bilateral hearing loss disability.

The Board granted an effective date of April 1, 2023 for the grant of service connection for prostate cancer with radical prostatectomy and erectile dysfunction.

The Board denied a compensable evaluation for scars of the anterior trunk and remanded claims for service connection for erectile dysfunction, hemorrhoids, hypertension, and an acquired psychiatric disability, to include major depressive disorder and anxiety.

The Board denied several claims for increased ratings and service connection, granted initial evaluations of 20 percent for radiculopathy in the left and right lower extremities, and dismissed a claim for service connection for erectile dysfunction.

The Board denied service connection for chronic fatigue syndrome, erectile dysfunction, bilateral flatfoot (pes planus), generalized anxiety disorder, persistent depressive disorder (dysthymic disorder), hypertension, pilonidal cyst, and sleep apnea due to a lack of evidence supporting the claims.

The Board granted service connection for erectile dysfunction as secondary to the Veteran's service-connected hypertension.

The Board granted an effective date of January 1, 2016, for entitlement to special monthly compensation based on loss of use of a creative organ due to service-connected erectile dysfunction.

The Board remands the claim for a more adequate medical opinion addressing causation and aggravation of erectile dysfunction by Meniere's Syndrome, including the use of Meclizine.